Success Metrics

Completion Rate
0%(0/1)
Active Trials
0(0%)
Terminated
1(17%)

Phase Distribution

Ph phase_3
1
17%
Ph phase_2
3
50%
Ph phase_1
2
33%

Phase Distribution

2

Early Stage

3

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Phase 1Safety & dosage
2(33.3%)
Phase 2Efficacy & side effects
3(50.0%)
Phase 3Large-scale testing
1(16.7%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

0.0%

0 of 1 finished

Non-Completion Rate

100.0%

1 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Terminated(1)
Other(4)

Detailed Status

unknown4
Terminated1
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
0.0%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (33.3%)
Phase 23 (50.0%)
Phase 31 (16.7%)

Trials by Status

terminated117%
not_yet_recruiting117%
unknown467%

Recent Activity

0 active trials
Showing 5 of 6
not_yet_recruitingphase_3

a Study of QL1706 or QL1604 in Patients With Limited-stage Small Cell Lung Cancer After Chemoradiotherapy.

NCT06789796
terminatedphase_2

QL1604 Plus Chemotherapy in Subjects With Stage IVB, Recurrent, or Metastatic Cervical Cancer

NCT04864782
unknownphase_1

A Phase I Study of QL1604 for Advanced Solid Tumors

NCT05801094
unknownphase_2

QL1604 Monotherapy for dMMR or MSI-H Advanced Solid Tumors

NCT04326829
unknownphase_1

A Phase Ib/II Trial to Evaluate the Safety and Efficacy of QL1706 in Patients With Advanced Hepatocellular Carcinoma

NCT05603039
View all 6 trials

Clinical Trials (6)

Showing 6 of 6 trials
NCT06789796Phase 3

a Study of QL1706 or QL1604 in Patients With Limited-stage Small Cell Lung Cancer After Chemoradiotherapy.

Not Yet Recruiting
NCT04864782Phase 2

QL1604 Plus Chemotherapy in Subjects With Stage IVB, Recurrent, or Metastatic Cervical Cancer

Terminated
NCT05801094Phase 1

A Phase I Study of QL1604 for Advanced Solid Tumors

Unknown
NCT04326829Phase 2

QL1604 Monotherapy for dMMR or MSI-H Advanced Solid Tumors

Unknown
NCT05603039Phase 1

A Phase Ib/II Trial to Evaluate the Safety and Efficacy of QL1706 in Patients With Advanced Hepatocellular Carcinoma

Unknown
NCT04435652Phase 2

A Study of QL1604 Plus Nab-paclitaxel Versus Paclitaxel in Subjects With Advanced Gastric Cancer.

Unknown

All 6 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
6